Skip to main content
logo
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
25.34
-0.17 (-0.67%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Nurix Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Net Income
294.88-264.46-193.57-143.95-180.36-117.19
Depreciation & Amortization
15.2718.2615.1312.259.615.28
Other Amortization
0.60.61.31.41.20.8
Loss (Gain) From Sale of Assets
0.250.090.030.560.010.13
Loss (Gain) From Sale of Investments
-6.34-10.32-11.29-5.420.431.71
Stock-Based Compensation
40.6637.9733.9333.6728.1315.8
Other Operating Activities
--0.29-0.2-
Change in Accounts Receivable
-20---6-6
Change in Accounts Payable
25.05-0.635.211.610.091.59
Change in Unearned Revenue
-21.78-36.98-28.5519.51-26.6314.25
Change in Income Taxes
-----3.64
Change in Other Net Operating Assets
50.736.014.94-1.011.52-4.37
Operating Cash Flow
379.31-249.47-172.58-81.37-159.81-84.37
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Capital Expenditures
-9.5-14-9.27-8.4-12.24-5.66
Investment in Securities
10.6161.86-248.4476.739.44-102.59
Investing Cash Flow
1.1147.85-257.7168.327.2-108.25

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Issuance of Common Stock
261.21238.64485.683.2222.43164.13
Repurchase of Common Stock
---0.02---
Other Financing Activities
----94.76-10.24
Financing Cash Flow
261.21238.64485.673.22117.19153.88

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Net Cash Flow
641.62137.0355.37-9.85-15.42-38.73

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Free Cash Flow
369.81-263.47-181.86-89.77-172.05-90.03
Free Cash Flow Growth
------
Free Cash Flow Margin
52.68%-313.73%-333.38%-116.60%-445.42%-302.61%
Free Cash Flow Per Share
3.38-3.04-2.71-1.65-3.54-2.10
Levered Free Cash Flow
233.34-143.99-85.9-41.93-79.42-37.7
Unlevered Free Cash Flow
233.34-143.99-85.9-41.93-79.42-37.7

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash Income Tax Paid
-----0.48
Change in Working Capital
34-31.6-18.420.12-19.029.11
SEC Filings: 10-K · 10-Q